Fast_Track_Internet_as_of_2010[removed]xls

First Page		Document Content
Pharmacology Cyclopropanes Bristol-Myers Squibb Gilead Sciences Non-nucleoside reverse transcriptase inhibitors Lamivudine Fixed-dose combination Efavirenz Cipla Chemistry Organic chemistry Organofluorides		Fast_Track_Internet_as_of_2010[removed]xls Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 270,57 KB Share Document on Facebook

	Case 3:16-cvDocument 1 FiledPage 1 ofDorian S. Berger, CA State Bar NoDaniel P. Hipskind, CA State Bar No DocID: 1rqYi - View Document
	GENERAL CONFORMITY CERTIFICATE This is an electronically controlled document. User is responsible for verifying and using the effective version. Pursuant to 15 U.S.C. § 2063(a), Gilead Sciences, Inc. certifies that bas DocID: 1pCJo - View Document
	Microsoft Word - GOCER-028.docx DocID: 1pkag - View Document
	GENERAL CONFORMITY CERTIFICATE Pursuant to 15 U.S.C. § 2063(a), Gilead Sciences, Inc. certifies that based on a reasonable testing program, the product referenced in this certificate complies with applicable regulations DocID: 1oSag - View Document
	BMS_Gilead_Logo_FINAL.eps DocID: 1m38a - View Document